Plasma antioxidant capacity in morbidly obese patients before and after weight loss. 2006

John Melissas, and Niki Malliaraki, and John A Papadakis, and Panagiotis Taflampas, and Marilena Kampa, and Elias Castanas
Bariatric Unit, Department of Surgical Oncology, University of Crete, Heraklion, Crete, Greece. melissas@med.uoc.gr

BACKGROUND Oxidative stress may play a critical role in the pathogenesis and development of obesity-associated co-morbidities. Reactive oxygen and nitrogen species are produced as a consequence of normal aerobic metabolism and removed and/or inactivated in vivo by both endogenous (uric acid, bilirubin, thiols) and diet-derived (exogenous) antioxidants. The purpose of this study is to measure the total plasma antioxidant capacity (TAC), as well as the corrected TAC (cTAC, an index of exogenous provided antioxidants) in morbidly obese patients before and after surgical weight reduction. METHODS 16 morbidly obese (5 male and 11 female) candidates for surgical intervention, median age 34 (range 22-56) years, median weight 128 (range 96-186) kg, median excess weight 62 (range 28-115) kg and median BMI 44.4 (range 33.7-60.1) kg/m2 were evaluated before and 6 months after implantation of an intragastric balloon. 15 healthy blood donors (4 male and 11 female) on a normal diet, median age 35 (range 21-52) years, median weight 64.3 (range 46-78) kg and median BMI 24.2 (range 23.7-25.2) kg/m2 were also evaluated. Blood samples for routine clinical chemistry, TAC and cTAC determination were drawn, and weight and BMI calculation were performed once in the control group, and in the morbidly obese patients (MO) before and 6 months after the balloon implantation. RESULTS 6 months after balloon placement, weight and BMI of the MO patients were statistically significantly reduced from the preoperative values (P<0.001). Plasma TAC and cTAC values in the MO group were significantly lower preoperatively, compared to the control group (P<0.05 and P<0.001 respectively). cTAC values in the MO patients increased significantly following weight loss (P<0.001) and were restored to normal. However, the postoperative TAC values in the MO group did not change significantly and remained lower than in the normal controls. A significant decrease (P<0.001) in uric acid values was also noticed in the MO group after weight loss. CONCLUSIONS Plasma TAC and cTAC values are impaired in morbidly obese patients. Weight loss from an intragastric balloon is associated with significant increase in plasma cTAC values. Plasma TAC values, after the weight loss remain unchanged, possibly due to a decrease in uric acid, an important endogenous antioxidant.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009767 Obesity, Morbid The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2. Morbid Obesity,Obesity, Severe,Morbid Obesities,Obesities, Morbid,Obesities, Severe,Severe Obesities,Severe Obesity
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D015431 Weight Loss Decrease in existing BODY WEIGHT. Weight Reduction,Loss, Weight,Losses, Weight,Reduction, Weight,Reductions, Weight,Weight Losses,Weight Reductions
D015905 Gastric Balloon An inflatable device implanted in the stomach as an adjunct to therapy of morbid obesity. Specific types include the silicone Garren-Edwards Gastric Bubble (GEGB), approved by the FDA in 1985, and the Ballobes Balloon. Ballobes Balloon,Garren-Edwards Gastric Bubble,Gastric Bubble,Ballobes Balloons,Balloon, Ballobes,Balloon, Gastric,Balloons, Ballobes,Balloons, Gastric,Bubble, Garren-Edwards Gastric,Bubble, Gastric,Bubbles, Gastric,Garren Edwards Gastric Bubble,Gastric Balloons,Gastric Bubble, Garren-Edwards,Gastric Bubbles

Related Publications

John Melissas, and Niki Malliaraki, and John A Papadakis, and Panagiotis Taflampas, and Marilena Kampa, and Elias Castanas
May 1989, Thorax,
John Melissas, and Niki Malliaraki, and John A Papadakis, and Panagiotis Taflampas, and Marilena Kampa, and Elias Castanas
August 2016, Obesity surgery,
John Melissas, and Niki Malliaraki, and John A Papadakis, and Panagiotis Taflampas, and Marilena Kampa, and Elias Castanas
April 2020, BMC endocrine disorders,
John Melissas, and Niki Malliaraki, and John A Papadakis, and Panagiotis Taflampas, and Marilena Kampa, and Elias Castanas
May 1981, The Journal of surgical research,
John Melissas, and Niki Malliaraki, and John A Papadakis, and Panagiotis Taflampas, and Marilena Kampa, and Elias Castanas
February 2007, Obesity surgery,
John Melissas, and Niki Malliaraki, and John A Papadakis, and Panagiotis Taflampas, and Marilena Kampa, and Elias Castanas
August 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
John Melissas, and Niki Malliaraki, and John A Papadakis, and Panagiotis Taflampas, and Marilena Kampa, and Elias Castanas
December 2007, Obesity surgery,
John Melissas, and Niki Malliaraki, and John A Papadakis, and Panagiotis Taflampas, and Marilena Kampa, and Elias Castanas
September 2016, Archives of biochemistry and biophysics,
John Melissas, and Niki Malliaraki, and John A Papadakis, and Panagiotis Taflampas, and Marilena Kampa, and Elias Castanas
November 2009, Obesity surgery,
John Melissas, and Niki Malliaraki, and John A Papadakis, and Panagiotis Taflampas, and Marilena Kampa, and Elias Castanas
August 2003, Obesity research,
Copied contents to your clipboard!